Is Sinovac Biotech Ltd. (SVA) A Good Stock to Buy?

As aggregate interest increased, specific money managers were breaking ground themselves. Pine River Capital Management initiated the most outsized position in Sinovac Biotech Ltd. (NASDAQ:SVA). Pine River Capital Management had $0.6 million invested in the company at the end of the quarter. Ken Griffin’s Citadel Investment Group also made a $0.1 million investment in the stock during the quarter.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as Sinovac Biotech Ltd. (NASDAQ:SVA) but similarly valued. We will take a look at CommunityOne Bancorp (NASDAQ:COB), Bill Barrett Corporation (NYSE:BBG), Cloud Peak Energy Inc. (NYSE:CLD), and PennyMac Mortgage Investment Trust (NASDAQ:PMTS). All of these stocks’ market caps match SVA’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
COB 4 6520 0
BBG 19 87696 0
CLD 13 43065 5
PMTS 12 14578 3

As you can see these stocks had an average of 12 hedge funds with bullish positions and the average amount invested in these stocks was $38 million. That figure was $26 million in SVA’s case. Bill Barrett Corporation (NYSE:BBG) is the most popular stock in this table. On the other hand CommunityOne Bancorp (NASDAQ:COB) is the least popular one with only 4 bullish hedge fund positions. Sinovac Biotech Ltd. (NASDAQ:SVA) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. In this regard BBG might be a better candidate to consider taking a long position in.

Disclosure: None